Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Am J Transplant. 2020 Feb 3;20(6):1619–1628. doi: 10.1111/ajt.15768

Figure 1. a: Immediate treatment group.

Figure 1

SVR = sustained virologic response 12 weeks after completion of treatment. DAA = direct-acting antiviral. *Treatment was commenced as soon as feasible after transplantation (1–5 post-operative days)

b: Reactive treatment group

SVR = sustained virologic response 12 weeks after completion of treatment. DAA = direct-acting antiviral.